{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:03:58Z","timestamp":1789603438374,"version":"build-2803163510"},"reference-count":211,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-CE13-0001-01"],"award-info":[{"award-number":["ANR-22-CE13-0001-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glucocorticoid receptor (GR) is a member of the nuclear hormone receptor family, which acts as a transcription factor when bound by glucocorticoid (GC) ligands. GR is expressed in nearly all tissue types and regulates essential processes such as inflammation, immune regulation and metabolism. Given its ubiquitous role, GR has frequently been associated with a wide range of illnesses, particularly in the fields of allergy, pulmonary, dermatology, rheumatology, or ophthalmology. It was reported that GCs either contribute to their development or serve as part of their treatment, making them the most prescribed drugs worldwide. GR activity and signaling is finely regulated by a network of post-translational modifications (PTMs). Indeed, PTMs can alter GR behavior and function by modifying its localization, stability, interaction with other proteins and transcriptional activity. Aside from the well-characterized phosphorylation events, additional PTMs are implicated in GR activity and their dysregulation has been described in various diseases. This review provides an integrated overview of current knowledge on GR PTMs, highlighting both mechanistic insights and their relevance in disease. We will present how aberrant PTMs contribute to extremely prevalent diseases, such as cancer, chronic inflammatory diseases, Alzheimer\u2019s disease and other neurological diseases. Special attention will be given to the specific readers of these PTMs and to the enzymes catalyzing these modifications, as they represent promising therapeutic targets.<\/jats:p>","DOI":"10.1186\/s12964-026-03015-7","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T12:55:07Z","timestamp":1781960107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["How post-translational modifications impact glucocorticoid receptor function in human pathologies"],"prefix":"10.1186","volume":"24","author":[{"given":"Z\u00e9lie","family":"Bouveret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludivine","family":"Pruvost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tr\u00e9dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Le Romancer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Poulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"3015_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000359984","volume":"100","author":"PJ Barnes","year":"2014","unstructured":"Barnes PJ. Glucocorticoids. Chem Immunol Allergy. 2014;100:311\u20136. https:\/\/doi.org\/10.1159\/000359984.","journal-title":"Chem Immunol Allergy"},{"key":"3015_CR2","doi-asserted-by":"publisher","first-page":"j1415","DOI":"10.1136\/bmj.j1415","volume":"357","author":"AK Waljee","year":"2017","unstructured":"Waljee AK, Rogers MAM, Lin P, Singal AG, Stein JD, Marks RM, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415. https:\/\/doi.org\/10.1136\/bmj.j1415.","journal-title":"BMJ"},{"key":"3015_CR3","volume-title":"StatPearls","author":"A Hodgens","year":"2025","unstructured":"Hodgens A, Sharman T. Corticosteroids. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"3015_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1210\/endrev\/bnae008","volume":"45","author":"J Lockett","year":"2024","unstructured":"Lockett J, Inder WJ, Clifton VL. The glucocorticoid receptor: isoforms, functions, and contribution to glucocorticoid sensitivity. Endocr Rev. 2024;45:593\u2013624. https:\/\/doi.org\/10.1210\/endrev\/bnae008.","journal-title":"Endocr Rev"},{"key":"3015_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1210\/en.2007-1364","volume":"149","author":"MJM Schaaf","year":"2008","unstructured":"Schaaf MJM, Champagne D, van Laanen IHC, van Wijk DCWA, Meijer AH, Meijer OC, et al. Discovery of a functional glucocorticoid receptor beta-isoform in zebrafish. Endocrinology. 2008;149:1591\u20139. https:\/\/doi.org\/10.1210\/en.2007-1364.","journal-title":"Endocrinology"},{"key":"3015_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00453-17","volume":"38","author":"J Min","year":"2018","unstructured":"Min J, Perera L, Krahn JM, Jewell CM, Moon AF, Cidlowski JA, et al. Probing dominant negative behavior of glucocorticoid receptor \u03b2 through a hybrid structural and biochemical approach. Mol Cell Biol. 2018;38:e00453\u201317. https:\/\/doi.org\/10.1128\/MCB.00453-17.","journal-title":"Mol Cell Biol"},{"issue":"16","key":"3015_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1096\/fj.01-0245com","volume":"2002","author":"J Galon","year":"2025","unstructured":"Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 2025;2002(16):61\u201371. https:\/\/doi.org\/10.1096\/fj.01-0245com. Cited 2025 Oct 21.","journal-title":"FASEB J"},{"issue":"286","key":"3015_CR8","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1074\/jbc.R110.179325","volume":"2011","author":"RH Oakley","year":"2025","unstructured":"Oakley RH, Cidlowski JA. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem. 2025;2011(286):3177\u201384. https:\/\/doi.org\/10.1074\/jbc.R110.179325. Cited 2025 Oct 9.","journal-title":"J Biol Chem"},{"key":"3015_CR9","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/pro.3496","volume":"27","author":"ER Weikum","year":"2018","unstructured":"Weikum ER, Liu X, Ortlund EA. The nuclear receptor superfamily: a structural perspective. Protein Sci. 2018;27:1876\u201392. https:\/\/doi.org\/10.1002\/pro.3496.","journal-title":"Protein Sci"},{"key":"3015_CR10","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1042\/BST20210419","volume":"49","author":"F Frank","year":"2021","unstructured":"Frank F, Ortlund EA, Liu X. Structural insights into glucocorticoid receptor function. Biochem Soc Trans. 2021;49:2333\u201343. https:\/\/doi.org\/10.1042\/BST20210419.","journal-title":"Biochem Soc Trans"},{"key":"3015_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/352497a0","volume":"352","author":"BF Luisi","year":"1991","unstructured":"Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 1991;352:497\u2013505. https:\/\/doi.org\/10.1038\/352497a0.","journal-title":"Nature"},{"key":"3015_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.1164265","volume":"324","author":"SH Meijsing","year":"2009","unstructured":"Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science. 2009;324:407\u201310. https:\/\/doi.org\/10.1126\/science.1164265.","journal-title":"Science"},{"issue":"110","key":"3015_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0092-8674(02)00817-6","volume":"2002","author":"RK Bledsoe","year":"2025","unstructured":"Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, et al. Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition. Cell. 2025;2002(110):93\u2013105. https:\/\/doi.org\/10.1016\/S0092-8674(02)00817-6. Cited 2025 Oct 7.","journal-title":"Cell"},{"key":"3015_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0021-9258(18)69528-6","volume":"235","author":"VB Mahesh","year":"2025","unstructured":"Mahesh VB, Ulrich F. Metabolism of cortisol and cortisone by various tissues and subcellular particles. J Biol Chem. 2025;235:356\u201360. https:\/\/doi.org\/10.1016\/S0021-9258(18)69528-6.","journal-title":"J Biol Chem"},{"issue":"48","key":"3015_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0960-0760(94)90153-8","volume":"1994","author":"E Maser","year":"2025","unstructured":"Maser E, Bannenberg G. The purification of 11\u03b2-hydroxysteroid dehydrogenase from mouse liver microsomes. J Steroid Biochem Mol Biol. 2025;1994(48):257\u201363. https:\/\/doi.org\/10.1016\/0960-0760(94)90153-8. Cited 2025 Oct 15.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3015_CR16","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1016\/0303-7207(94)90176-7","volume":"105","author":"AL Albiston","year":"1994","unstructured":"Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol. 1994;105:R11-17. https:\/\/doi.org\/10.1016\/0303-7207(94)90176-7.","journal-title":"Mol Cell Endocrinol"},{"key":"3015_CR17","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.4155\/bio-2018-0182","volume":"10","author":"Y Wang","year":"2018","unstructured":"Wang Y, Fujioka N, Xing C. Quantitative profiling of cortisol metabolites in human urine by high-resolution accurate-mass MS. Bioanalysis. 2018;10:2015\u201326. https:\/\/doi.org\/10.4155\/bio-2018-0182.","journal-title":"Bioanalysis"},{"key":"3015_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/07391102.2018.1433554","volume":"37","author":"M Kallubai","year":"2019","unstructured":"Kallubai M, Reddy SP, Dubey S, Ramachary DB, Subramanyam R. Spectroscopic evaluation of synthesized 5\u03b2-dihydrocortisol and 5\u03b2-dihydrocortisol acetate binding mechanism with human serum albumin and their role in anticancer activity. J Biomol Struct Dyn. 2019;37:623\u201340. https:\/\/doi.org\/10.1080\/07391102.2018.1433554.","journal-title":"J Biomol Struct Dyn"},{"key":"3015_CR19","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1046\/j.1365-2826.2000.00568.x","volume":"12","author":"J Haller","year":"2000","unstructured":"Haller J, Halasz J, Mikics E, Kruk MR, Makara GB. Ultradian corticosterone rhythm and the propensity to behave aggressively in male rats. J Neuroendocrinol. 2000;12:937\u201340. https:\/\/doi.org\/10.1046\/j.1365-2826.2000.00568.x.","journal-title":"J Neuroendocrinol"},{"issue":"31","key":"3015_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00281-009-0159-2","volume":"2009","author":"M Noti","year":"2025","unstructured":"Noti M, Sidler D, Brunner T. Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean? Semin Immunopathol. 2025;2009(31):237\u201348. https:\/\/doi.org\/10.1007\/s00281-009-0159-2. Cited 2025 Oct 7.","journal-title":"Semin Immunopathol"},{"issue":"301","key":"3015_CR21","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1152\/ajpendo.00100.2011","volume":"2011","author":"MD Taves","year":"2025","unstructured":"Taves MD, Gomez-Sanchez CE, Soma KK. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am J Physiol Endocrinol Metab. 2025;2011(301):E11-24. https:\/\/doi.org\/10.1152\/ajpendo.00100.2011. Cited 2025 Oct 7.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"103","key":"3015_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.steroids.2015.06.010","volume":"2015","author":"G Talaber","year":"2025","unstructured":"Talaber G, Jondal M, Okret S. Local glucocorticoid production in the thymus. Steroids. 2025;2015(103):58\u201363. https:\/\/doi.org\/10.1016\/j.steroids.2015.06.010. Cited 2025 Oct 7.","journal-title":"Steroids"},{"issue":"200","key":"3015_CR23","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.4049\/jimmunol.1701328","volume":"2018","author":"PR Mittelstadt","year":"2025","unstructured":"Mittelstadt PR, Taves MD, Ashwell JD. De novo glucocorticoid synthesis by thymic epithelial cells regulates antigen-specific thymocyte selection. J Immunol. 2025;2018(200):1988\u201394. https:\/\/doi.org\/10.4049\/jimmunol.1701328. Cited 2025 Oct 7.","journal-title":"J Immunol"},{"issue":"359","key":"3015_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cccn.2005.03.044","volume":"2005","author":"JG Lewis","year":"2025","unstructured":"Lewis JG, Bagley CJ, Elder PA, Bachmann AW, Torpy DJ. Plasma free cortisol fraction reflects levels of functioning corticosteroid-binding globulin. Clin Chim Acta. 2025;2005(359):189\u201394. https:\/\/doi.org\/10.1016\/j.cccn.2005.03.044. Cited 2025 Oct 7.","journal-title":"Clin Chim Acta"},{"issue":"73","key":"3015_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0006-291X(76)90875-5","volume":"1976","author":"MK Agarwal","year":"2025","unstructured":"Agarwal MK. Evidence that natural vs synthetic steroid hormones bind to physicochemically distinct cellular receptors. Biochem Biophys Res Commun. 2025;1976(73):767\u201372. https:\/\/doi.org\/10.1016\/0006-291X(76)90875-5. Cited 2025 Oct 7.","journal-title":"Biochem Biophys Res Commun"},{"key":"3015_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4187\/respcare.06314","volume":"63","author":"DM Williams","year":"2018","unstructured":"Williams DM. Clinical pharmacology of corticosteroids. Respir Care. 2018;63:655\u201370. https:\/\/doi.org\/10.4187\/respcare.06314.","journal-title":"Respir Care"},{"issue":"80","key":"3015_CR27","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/bcp.12637","volume":"2015","author":"PT Daley-Yates","year":"2025","unstructured":"Daley-Yates PT. Inhaled corticosteroids: potency, dose equivalence and therapeutic index. Br J Clin Pharmacol. 2025;2015(80):372\u201380. https:\/\/doi.org\/10.1111\/bcp.12637. Cited 2025 Oct 7.","journal-title":"Br J Clin Pharmacol"},{"issue":"320","key":"3015_CR28","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","volume":"2000","author":"PS Burge","year":"2025","unstructured":"Burge PS, Calverley PMA, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2025;2000(320):1297\u2013303. https:\/\/doi.org\/10.1136\/bmj.320.7245.1297. Cited 2025 Oct 7.","journal-title":"BMJ"},{"key":"3015_CR29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/BF03349763","volume":"18","author":"M Shimojo","year":"1995","unstructured":"Shimojo M, Stewart PM. Apparent mineralocorticoid excess syndromes. J Endocrinol Invest. 1995;18:518\u201332. https:\/\/doi.org\/10.1007\/BF03349763.","journal-title":"J Endocrinol Invest"},{"issue":"114","key":"3015_CR30","doi-asserted-by":"publisher","first-page":"E9346","DOI":"10.1073\/pnas.1707965114","volume":"2017","author":"M Voisin","year":"2025","unstructured":"Voisin M, de Medina P, Mallinger A, Dalenc F, Huc-Claustre E, Leignadier J, et al. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor. Proc Natl Acad Sci U S A. 2025;2017(114):E9346\u201355. https:\/\/doi.org\/10.1073\/pnas.1707965114. Cited 2025 Oct 7.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3015_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24845-8","volume":"12","author":"C Pan","year":"2021","unstructured":"Pan C, Kang J, Hwang JS, Li J, Boese AC, Wang X, et al. Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1. Nat Commun. 2021;12:4960. https:\/\/doi.org\/10.1038\/s41467-021-24845-8.","journal-title":"Nat Commun"},{"issue":"3","key":"3015_CR32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/j.1460-2075.1984.tb01879.x","volume":"1984","author":"S Bourgeois","year":"2025","unstructured":"Bourgeois S, Pfahl M, Baulieu EE. DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486. EMBO J. 2025;1984(3):751\u20135. https:\/\/doi.org\/10.1002\/j.1460-2075.1984.tb01879.x. Cited 2025 Oct 14.","journal-title":"EMBO J"},{"key":"3015_CR33","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1210\/jc.2011-3350","volume":"97","author":"M Fleseriu","year":"2012","unstructured":"Fleseriu M, Biller BMK, Findling JW, Molitch ME, Schteingart DE, Gross C, et al. Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab. 2012;97:2039\u201349. https:\/\/doi.org\/10.1210\/jc.2011-3350.","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"3015_CR34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.4103\/2230-8210.98048","volume":"2012","author":"N Magon","year":"2025","unstructured":"Magon N, Chauhan M, Goel P, Ruprai RK. The many lives of mifepristone: multi-glandular exaptation of an endocrine molecule. Indian J Endocrinol Metab. 2025;2012(16):670\u20131. https:\/\/doi.org\/10.4103\/2230-8210.98048. Cited 2025 Oct 14.","journal-title":"Indian J Endocrinol Metab"},{"issue":"45","key":"3015_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tibs.2020.02.006","volume":"2020","author":"MR Stallcup","year":"2025","unstructured":"Stallcup MR, Poulard C. Gene-specific actions of transcriptional coregulators facilitate physiological plasticity: evidence for a physiological coregulator code. Trends Biochem Sci. 2025;2020(45):497\u2013510. https:\/\/doi.org\/10.1016\/j.tibs.2020.02.006.","journal-title":"Trends Biochem Sci"},{"key":"3015_CR36","doi-asserted-by":"publisher","unstructured":"Hunt HJ, Belanoff JK, Walters I, Gourdet B, Thomas J, Barton N, et al. Identification of the clinical candidate (R)-(1-(4-fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): a selective glucocorticoid receptor (GR) antagonist. J Med Chem. 2017(8). https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00162.","DOI":"10.1021\/acs.jmedchem.7b00162"},{"key":"3015_CR37","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-22-0263","volume":"256","author":"EMG Viho","year":"2022","unstructured":"Viho EMG, Kroon J, Feelders RA, Houtman R, van den Dungen ESR, Pereira AM, et al. Peripheral glucocorticoid receptor antagonism by relacorilant with modest HPA axis disinhibition. J Endocrinol. 2022;256:e220263. https:\/\/doi.org\/10.1530\/JOE-22-0263.","journal-title":"J Endocrinol"},{"issue":"246","key":"3015_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1530\/JOE-19-0486","volume":"2020","author":"LL Koorneef","year":"2025","unstructured":"Koorneef LL, Kroon J, Viho EMG, Wahl LF, Heckmans KML, van Dorst MMAR, et al. The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity. J Endocrinol. 2025;2020(246):79\u201392. https:\/\/doi.org\/10.1530\/JOE-19-0486. Cited 2025 Oct 14.","journal-title":"J Endocrinol"},{"issue":"30","key":"3015_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.eprac.2023.09.011","volume":"2024","author":"DM Donegan","year":"2025","unstructured":"Donegan DM, Pivonello R, Stigliano A, Lardo P, Kearney T, Mez\u0151si E, et al. Relacorilant, a selective glucocorticoid receptor modulator in development for the treatment of patients with cushing syndrome, does not cause prolongation of the cardiac QT interval. Endocr Pract. 2025;2024(30):11\u20138. https:\/\/doi.org\/10.1016\/j.eprac.2023.09.011.Cited 2025 Oct 14.","journal-title":"Endocr Pract"},{"issue":"12","key":"3015_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fendo.2021.662865","volume":"2021","author":"R Pivonello","year":"2025","unstructured":"Pivonello R, Bancos I, Feelders RA, Kargi AY, Kerr JM, Gordon MB, et al. Relacorilant, a selective glucocorticoid receptor modulator, induces clinical improvements in patients with Cushing syndrome: results from a prospective, open-label Phase 2 study. Front Endocrinol. 2025;2021(12):28. https:\/\/doi.org\/10.3389\/fendo.2021.662865. Cited 2025 Jan 28.","journal-title":"Front Endocrinol"},{"issue":"15","key":"3015_CR41","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-21-4363","volume":"28","author":"PN Munster","year":"2022","unstructured":"Munster PN, Greenstein AE, Fleming GF, Borazanci E, Sharma MR, Custodio JM, et al. Overcoming taxane resistance: preclinical and phase 1 studies of relacorilant, a selective glucocorticoid receptor modulator, with nab-paclitaxel in solid tumors. Clin Cancer Res. 2022;28(15):3214\u201324.","journal-title":"Clin Cancer Res"},{"issue":"41","key":"3015_CR42","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1200\/JCO.22.02624","volume":"2023","author":"N Colombo","year":"2025","unstructured":"Colombo N, Van Gorp T, Matulonis UA, Oaknin A, Grisham RN, Fleming GF, et al. Relacorilant + Nab-Paclitaxel in patients with recurrent, platinum-resistant ovarian cancer: a three-arm, randomized, controlled, open-label Phase II study. J Clin Oncol. 2025;2023(41):4779\u201389. https:\/\/doi.org\/10.1200\/JCO.22.02624. Cited 2025 Oct 14.","journal-title":"J Clin Oncol"},{"issue":"30","key":"3015_CR43","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1158\/1078-0432.CCR-23-3636","volume":"2024","author":"KB Desai","year":"2025","unstructured":"Desai KB, Serritella AV, Stadler WM, O\u2019Donnell PH, Sweis RF, Szmulewitz RZ. A phase I trial of enzalutamide plus selective glucocorticoid receptor modulator relacorilant in patients with metastatic castration resistant prostate cancer. Clin Cancer Res. 2025;2024(30):2384\u201392. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-3636. Cited 2025 Oct 14.","journal-title":"Clin Cancer Res"},{"key":"3015_CR44","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/S0140-6736(25)01040-2","volume":"405","author":"AB Olawaiye","year":"2025","unstructured":"Olawaiye AB, Gladieff L, O\u2019Malley DM, Kim J-W, Garbaos G, Salutari V, et al. Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial. Lancet. 2025;405:2205\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(25)01040-2.","journal-title":"Lancet"},{"issue":"12","key":"3015_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fendo.2021.793262","volume":"2022","author":"R Pivonello","year":"2025","unstructured":"Pivonello R, Munster PN, Terzolo M, Ferrigno R, Simeoli C, Puglisi S, et al. Glucocorticoid receptor antagonism upregulates somatostatin receptor subtype 2 expression in acth-producing neuroendocrine tumors: new insight based on the selective glucocorticoid receptor modulator relacorilant. Front Endocrinol Frontiers. 2025;2022(12):15. https:\/\/doi.org\/10.3389\/fendo.2021.793262. Cited 2025 Oct 15.","journal-title":"Front Endocrinol Frontiers"},{"issue":"275","key":"3015_CR46","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1074\/jbc.275.10.6894","volume":"2000","author":"Y Morishima","year":"2025","unstructured":"Morishima Y, Kanelakis KC, Silverstein AM, Dittmar KD, Estrada L, Pratt WB. The Hsp organizer protein hop enhances the rate of but is not essential for glucocorticoid receptor folding by the multiprotein Hsp90-based chaperone system*. J Biol Chem. 2025;2000(275):6894\u2013900. https:\/\/doi.org\/10.1074\/jbc.275.10.6894. Cited 2025 Oct 7.","journal-title":"J Biol Chem"},{"key":"3015_CR47","doi-asserted-by":"publisher","first-page":"36980","DOI":"10.1074\/jbc.274.52.36980","volume":"274","author":"AM Silverstein","year":"1999","unstructured":"Silverstein AM, Galigniana MD, Kanelakis KC, Radanyi C, Renoir J-M, Pratt WB. Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90, and cytoplasmic dynein*. J Biol Chem. 1999;274:36980\u20136. https:\/\/doi.org\/10.1074\/jbc.274.52.36980.","journal-title":"J Biol Chem"},{"issue":"273","key":"3015_CR48","doi-asserted-by":"publisher","first-page":"35194","DOI":"10.1074\/jbc.273.52.35194","volume":"1998","author":"S Chen","year":"2025","unstructured":"Chen S, Smith DF. Hop as an adaptor in the heat shock protein 70 (Hsp70) and Hsp90 chaperone machinery*. J Biol Chem. 2025;1998(273):35194\u2013200. https:\/\/doi.org\/10.1074\/jbc.273.52.35194.","journal-title":"J Biol Chem"},{"issue":"22","key":"3015_CR49","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/emboj\/cdg108","volume":"2003","author":"DL Riggs","year":"2025","unstructured":"Riggs DL, Roberts PJ, Chirillo SC, Cheung-Flynn J, Prapapanich V, Ratajczak T, et al. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J. 2025;2003(22):1158\u201367. https:\/\/doi.org\/10.1093\/emboj\/cdg108. Cited 2025 Oct 7.","journal-title":"EMBO J"},{"issue":"29","key":"3015_CR50","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1128\/MCB.00649-09","volume":"2009","author":"PC Echeverr\u00eda","year":"2025","unstructured":"Echeverr\u00eda PC, Mazaira G, Erlejman A, Gomez-Sanchez C, Pilipuk GP, Galigniana MD. Nuclear import of the glucocorticoid receptor-hsp90 complex through the nuclear pore complex is mediated by its interaction with Nup62 and importin \u03b2. Mol Cell Biol. 2025;2009(29):4788\u201397. https:\/\/doi.org\/10.1128\/MCB.00649-09.","journal-title":"Mol Cell Biol"},{"issue":"15","key":"3015_CR51","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1091\/mbc.E03-11-0839","volume":"2004","author":"ND Freedman","year":"2025","unstructured":"Freedman ND, Yamamoto KR. Importin 7 and importin \u03b1\/importin \u03b2 are nuclear import receptors for the glucocorticoid receptor. Mol Biol Cell. 2025;2004(15):2276\u201386. https:\/\/doi.org\/10.1091\/mbc.E03-11-0839.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"3015_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4161\/nucl.1.4.11743","volume":"2010","author":"MD Galigniana","year":"2025","unstructured":"Galigniana MD, Echeverr\u00eda PC, Erlejman AG, Piwien-Pilipuk G. Role of molecular chaperones and TPR-domain proteins in the cytoplasmic transport of steroid receptors and their passage through the nuclear pore. Nucleus. 2025;2010(1):299\u2013308. https:\/\/doi.org\/10.4161\/nucl.1.4.11743. Cited 2025 Oct 21.","journal-title":"Nucleus"},{"issue":"280","key":"3015_CR53","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1074\/jbc.M407498200","volume":"2005","author":"GM Wochnik","year":"2025","unstructured":"Wochnik GM, R\u00fcegg J, Abel GA, Schmidt U, Holsboer F, Rein T. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells*. J Biol Chem. 2025;2005(280):4609\u201316. https:\/\/doi.org\/10.1074\/jbc.M407498200.","journal-title":"J Biol Chem"},{"issue":"152","key":"3015_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1083\/jcb.152.1.127","volume":"2001","author":"JM Holaska","year":"2025","unstructured":"Holaska JM, Black BE, Love DC, Hanover JA, Leszyk J, Paschal BM. Calreticulin is a receptor for nuclear export. J Cell Biol. 2025;2001(152):127\u201340. https:\/\/doi.org\/10.1083\/jcb.152.1.127. Cited 2025 Oct 7.","journal-title":"J Cell Biol"},{"issue":"22","key":"3015_CR55","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.1128\/MCB.22.17.6286-6297.2002","volume":"2002","author":"JM Holaska","year":"2025","unstructured":"Holaska JM, Black BE, Rastinejad F, Paschal BM. Ca2+-dependent nuclear export mediated by calreticulin. Mol Cell Biol. 2025;2002(22):6286\u201397. https:\/\/doi.org\/10.1128\/MCB.22.17.6286-6297.2002. Cited 2025 Oct 7.","journal-title":"Mol Cell Biol"},{"key":"3015_CR56","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1023\/a:1007652908104","volume":"17","author":"B Hinz","year":"2000","unstructured":"Hinz B, Hirschelmann R. Dexamethasone megadoses stabilize rat liver lysosomal membranes by non-genomic and genomic effects. Pharm Res. 2000;17:1489\u201393. https:\/\/doi.org\/10.1023\/a:1007652908104.","journal-title":"Pharm Res"},{"key":"3015_CR57","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/sj.embor.7400775","volume":"7","author":"M L\u00f6wenberg","year":"2006","unstructured":"L\u00f6wenberg M, Verhaar AP, Bilderbeek J, van Marle J, Buttgereit F, Peppelenbosch MP, et al. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep. 2006;7:1023\u20139. https:\/\/doi.org\/10.1038\/sj.embor.7400775.","journal-title":"EMBO Rep"},{"issue":"8","key":"3015_CR58","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nm0502-473","volume":"2002","author":"A Hafezi-Moghadam","year":"2025","unstructured":"Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier J-C, Rebsamen MC, et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2025;2002(8):473\u20139. https:\/\/doi.org\/10.1038\/nm0502-473. Cited 2025 Oct 9.","journal-title":"Nat Med"},{"key":"3015_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0823-8","volume":"19","author":"RL Flaherty","year":"2017","unstructured":"Flaherty RL, Owen M, Fagan-Murphy A, Intabli H, Healy D, Patel A, et al. Glucocorticoids induce production of reactive oxygen species\/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer. Breast Cancer Res. 2017;19:35. https:\/\/doi.org\/10.1186\/s13058-017-0823-8.","journal-title":"Breast Cancer Res"},{"key":"3015_CR60","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/me.2003-0350","volume":"18","author":"H Leis","year":"2004","unstructured":"Leis H, Page A, Ram\u00edrez A, Bravo A, Segrelles C, Paramio J, et al. Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway. Mol Endocrinol. 2004;18:303\u201311. https:\/\/doi.org\/10.1210\/me.2003-0350.","journal-title":"Mol Endocrinol"},{"issue":"12","key":"3015_CR61","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1074\/mcp.M112.022947","volume":"2013","author":"S Vernocchi","year":"2025","unstructured":"Vernocchi S, Battello N, Schmitz S, Revets D, Billing AM, Turner JD, et al. Membrane glucocorticoid receptor activation induces proteomic changes aligning with classical glucocorticoid effects. Mol Cell Proteomics. 2025;2013(12):1764\u201379. https:\/\/doi.org\/10.1074\/mcp.M112.022947. Cited 2025 Oct 9.","journal-title":"Mol Cell Proteomics"},{"issue":"108","key":"3015_CR62","doi-asserted-by":"publisher","first-page":"16657","DOI":"10.1073\/pnas.1102821108","volume":"2011","author":"RA Samarasinghe","year":"2025","unstructured":"Samarasinghe RA, Di Maio R, Volonte D, Galbiati F, Lewis M, Romero G, et al. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc Natl Acad Sci U S A. 2025;2011(108):16657\u201362. https:\/\/doi.org\/10.1073\/pnas.1102821108. Cited 2025 Oct 9.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3015_CR63","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1078\/S0171-9335(04)70033-3","volume":"79","author":"K Scheller","year":"2000","unstructured":"Scheller K, Sekeris CE, Krohne G, Hock R, Hansen IA, Scheer U. Localization of glucocorticoid hormone receptors in mitochondria of human cells. Eur J Cell Biol. 2000;79:299\u2013307. https:\/\/doi.org\/10.1078\/S0171-9335(04)70033-3.","journal-title":"Eur J Cell Biol"},{"key":"3015_CR64","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.bbamcr.2011.05.014","volume":"1813","author":"A-M Psarra","year":"2011","unstructured":"Psarra A-M, Sekeris CE. Glucocorticoids induce mitochondrial gene transcription in HepG2 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2011;1813:1814\u201321. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.05.014.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"3015_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/srep26419","volume":"6","author":"DJ Morgan","year":"2016","unstructured":"Morgan DJ, Poolman TM, Williamson AJK, Wang Z, Clark NR, Ma\u2019ayan A, et al. Glucocorticoid receptor isoforms direct distinct mitochondrial programs to regulate ATP production. Sci Rep. 2016;6:26419. https:\/\/doi.org\/10.1038\/srep26419.","journal-title":"Sci Rep"},{"issue":"203","key":"3015_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1084\/jem.20050433","volume":"2006","author":"RV Sionov","year":"2025","unstructured":"Sionov RV, Cohen O, Kfir S, Zilberman Y, Yefenof E. Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis. J Exp Med. 2025;2006(203):189\u2013201. https:\/\/doi.org\/10.1084\/jem.20050433. Cited 2025 Oct 9.","journal-title":"J Exp Med"},{"key":"3015_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0418-y","volume":"15","author":"BJ Schiller","year":"2014","unstructured":"Schiller BJ, Chodankar R, Watson LC, Stallcup MR, Yamamoto KR. Glucocorticoid receptor binds half sites as a monomer and regulates specific target genes. Genome Biol. 2014;15:418. https:\/\/doi.org\/10.1186\/s13059-014-0418-y.","journal-title":"Genome Biol"},{"issue":"145","key":"3015_CR68","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cell.2011.03.027","volume":"2011","author":"M Surjit","year":"2025","unstructured":"Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, Metzger D, et al. Widespread negative response elements mediate direct repression by agonist- liganded glucocorticoid receptor. Cell. 2025;2011(145):224\u201341. https:\/\/doi.org\/10.1016\/j.cell.2011.03.027. Cited 2025 Oct 7.","journal-title":"Cell"},{"key":"3015_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nsmb.2456","volume":"20","author":"WH Hudson","year":"2013","unstructured":"Hudson WH, Youn C, Ortlund EA. The structural basis of direct glucocorticoid-mediated transrepression. Nat Struct Mol Biol. 2013;20:53\u20138. https:\/\/doi.org\/10.1038\/nsmb.2456.","journal-title":"Nat Struct Mol Biol"},{"key":"3015_CR70","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1101\/gr.118042.110","volume":"21","author":"NAS Rao","year":"2011","unstructured":"Rao NAS, McCalman MT, Moulos P, Francoijs K-J, Chatziioannou A, Kolisis FN, et al. Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes. Genome Res. 2011;21:1404\u201316. https:\/\/doi.org\/10.1101\/gr.118042.110.","journal-title":"Genome Res"},{"key":"3015_CR71","doi-asserted-by":"publisher","first-page":"8596","DOI":"10.1093\/nar\/gkx509","volume":"45","author":"ER Weikum","year":"2017","unstructured":"Weikum ER, de Vera IMS, Nwachukwu JC, Hudson WH, Nettles KW, Kojetin DJ, et al. Tethering not required: the glucocorticoid receptor binds directly to activator protein-1 recognition motifs to repress inflammatory genes. Nucleic Acids Res. 2017;45:8596\u2013608. https:\/\/doi.org\/10.1093\/nar\/gkx509.","journal-title":"Nucleic Acids Res"},{"key":"3015_CR72","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1126\/science.2119054","volume":"249","author":"MI Diamond","year":"1990","unstructured":"Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science. 1990;249:1266\u201372. https:\/\/doi.org\/10.1126\/science.2119054.","journal-title":"Science"},{"key":"3015_CR73","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1158\/1541-7786.MCR-11-0423-T","volume":"10","author":"HD Ritter","year":"2012","unstructured":"Ritter HD, Antonova L, Mueller CR. The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta. Mol Cancer Res. 2012;10:558\u201369. https:\/\/doi.org\/10.1158\/1541-7786.MCR-11-0423-T.","journal-title":"Mol Cancer Res"},{"key":"3015_CR74","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/1471-2407-14-275","volume":"14","author":"HD Ritter","year":"2014","unstructured":"Ritter HD, Mueller CR. Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells. BMC Cancer. 2014;14:275. https:\/\/doi.org\/10.1186\/1471-2407-14-275.","journal-title":"BMC Cancer"},{"key":"3015_CR75","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/mend.12.2.0065","volume":"12","author":"XF Ding","year":"1998","unstructured":"Ding XF, Anderson CM, Ma H, Hong H, Uht RM, Kushner PJ, et al. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol. 1998;12:302\u201313. https:\/\/doi.org\/10.1210\/mend.12.2.0065.","journal-title":"Mol Endocrinol"},{"issue":"17","key":"3015_CR76","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1128\/mcb.17.2.895","volume":"1997","author":"AK Ostlund Farrants","year":"2025","unstructured":"Ostlund Farrants AK, Blomquist P, Kwon H, Wrange O. Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI\/SNF complex. Mol Cell Biol. 2025;1997(17):895\u2013905. https:\/\/doi.org\/10.1128\/mcb.17.2.895. Cited 2025 Oct 9.","journal-title":"Mol Cell Biol"},{"key":"3015_CR77","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1210\/me.2005-0318","volume":"20","author":"W Chen","year":"2006","unstructured":"Chen W, Rogatsky I, Garabedian MJ. MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor. Mol Endocrinol. 2006;20:560\u201372. https:\/\/doi.org\/10.1210\/me.2005-0318.","journal-title":"Mol Endocrinol"},{"issue":"277","key":"3015_CR78","doi-asserted-by":"publisher","first-page":"26238","DOI":"10.1074\/jbc.M203268200","volume":"2002","author":"M Schulz","year":"2025","unstructured":"Schulz M, Eggert M, Baniahmad A, Dostert A, Heinzel T, Renkawitz R. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding*. J Biol Chem. 2025;2002(277):26238\u201343. https:\/\/doi.org\/10.1074\/jbc.M203268200. Cited 2025 Jan 28.","journal-title":"J Biol Chem"},{"key":"3015_CR79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1877-1173(09)87007-5","volume":"87","author":"MD Stewart","year":"2009","unstructured":"Stewart MD, Wong J. Nuclear receptor repression: regulatory mechanisms and physiological implications. Prog Mol Biol Transl Sci. 2009;87:235\u201359. https:\/\/doi.org\/10.1016\/S1877-1173(09)87007-5.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3015_CR80","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1126\/science.284.5423.2174","volume":"284","author":"D Chen","year":"1999","unstructured":"Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, et al. Regulation of transcription by a protein methyltransferase. Science. 1999;284:2174\u20137. https:\/\/doi.org\/10.1126\/science.284.5423.2174.","journal-title":"Science"},{"key":"3015_CR81","doi-asserted-by":"publisher","first-page":"19673","DOI":"10.1073\/pnas.1211803109","volume":"109","author":"D Bittencourt","year":"2012","unstructured":"Bittencourt D, Wu D-Y, Jeong KW, Gerke DS, Herviou L, Ianculescu I, et al. G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of glucocorticoid receptor target genes. Proc Natl Acad Sci U S A. 2012;109:19673\u20138. https:\/\/doi.org\/10.1073\/pnas.1211803109.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3015_CR82","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302009","volume":"6","author":"LM Noureddine","year":"2023","unstructured":"Noureddine LM, Ablain J, Surmieliova-Garn\u00e8s A, Jacquemetton J, Pham TH, Marangoni E, et al. PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer. Life Sci Alliance. 2023;6:e202302009. https:\/\/doi.org\/10.26508\/lsa.202302009.","journal-title":"Life Sci Alliance"},{"key":"3015_CR83","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.15252\/embr.201744060","volume":"18","author":"C Poulard","year":"2017","unstructured":"Poulard C, Bittencourt D, Wu D-Y, Hu Y, Gerke DS, Stallcup MR. A post-translational modification switch controls coactivator function of histone methyltransferases G9a and GLP. EMBO Rep. 2017;18:1442\u201359. https:\/\/doi.org\/10.15252\/embr.201744060.","journal-title":"EMBO Rep"},{"issue":"115","key":"3015_CR84","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1182\/blood-2009-05-223081","volume":"2010","author":"JC van Galen","year":"2025","unstructured":"van Galen JC, Kuiper RP, van Emst L, Levers M, Tijchon E, Scheijen B, et al. BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia. Blood. 2025;2010(115):4810\u20139. https:\/\/doi.org\/10.1182\/blood-2009-05-223081. Cited 2025 Oct 15.","journal-title":"Blood"},{"key":"3015_CR85","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1016\/j.celrep.2019.05.062","volume":"27","author":"EA Clark","year":"2019","unstructured":"Clark EA, Wu F, Chen Y, Kang P, Kaiser UB, Fang R, et al. GR and LSD1\/KDM1A-targeted gene activation requires selective H3K4me2 demethylation at enhancers. Cell Rep. 2019;27:3522-3532.e3. https:\/\/doi.org\/10.1016\/j.celrep.2019.05.062.","journal-title":"Cell Rep"},{"key":"3015_CR86","doi-asserted-by":"publisher","DOI":"10.1177\/1550762918801072","volume":"15","author":"M Ohno","year":"2018","unstructured":"Ohno M, Negishi M. GR utilizes a co-chaperone cytoplasmic CAR retention protein to form an N\/C interaction. Nucl Recept Signal. 2018;15:1550762918801072. https:\/\/doi.org\/10.1177\/1550762918801072.","journal-title":"Nucl Recept Signal"},{"issue":"41","key":"3015_CR87","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41401-019-0309-6","volume":"2020","author":"Y Ren","year":"2026","unstructured":"Ren Y, Xu X, Mao C, Han K, Xu Y, Cao B, et al. RNF6 promotes myeloma cell proliferation and survival by inducing glucocorticoid receptor polyubiquitination. Acta Pharmacol Sin. 2026;2020(41):394\u2013403. https:\/\/doi.org\/10.1038\/s41401-019-0309-6. Cited 2026 May 20.","journal-title":"Acta Pharmacol Sin"},{"key":"3015_CR88","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011479","volume":"13","author":"J Wang","year":"2025","unstructured":"Wang J, Xie Y, Liu L, Rong S, Cai H, Zeng H, et al. O-GlcNAc transferase promotes immune evasion and immunotherapy resistance in uterine corpus endometrial cancer by targeting the glucocorticoid receptor. J Immunother Cancer. 2025;13:e011479. https:\/\/doi.org\/10.1136\/jitc-2025-011479.","journal-title":"J Immunother Cancer"},{"issue":"31","key":"3015_CR89","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1128\/MCB.05866-11","volume":"2011","author":"AJ Galliher-Beckley","year":"2023","unstructured":"Galliher-Beckley AJ, Williams JG, Cidlowski JA. Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling \u25bf. Mol Cell Biol. 2023;2011(31):4663\u201375. https:\/\/doi.org\/10.1128\/MCB.05866-11. Cited 2025 Oct 6.","journal-title":"Mol Cell Biol"},{"key":"3015_CR90","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ccr.2013.10.022","volume":"24","author":"E Piovan","year":"2013","unstructured":"Piovan E, Yu J, Tosello V, Herranz D, Ambesi-Impiombato A, Da Silva AC, et al. Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia. Cancer Cell. 2013;24:766\u201376. https:\/\/doi.org\/10.1016\/j.ccr.2013.10.022.","journal-title":"Cancer Cell"},{"issue":"439","key":"3015_CR91","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.mce.2016.10.002","volume":"2017","author":"T Habib","year":"2023","unstructured":"Habib T, Sadoun A, Nader N, Suzuki S, Liu W, Jithesh PV, et al. AKT1 has dual actions on the glucocorticoid receptor by cooperating with 14\u20133-3. Mol Cell Endocrinol. 2023;2017(439):431\u201343. https:\/\/doi.org\/10.1016\/j.mce.2016.10.002. Cited 2025 Oct 18.","journal-title":"Mol Cell Endocrinol"},{"issue":"278","key":"3015_CR92","doi-asserted-by":"publisher","first-page":"25651","DOI":"10.1074\/jbc.M302818200","volume":"2003","author":"T Kino","year":"2025","unstructured":"Kino T, Souvatzoglou E, De Martino MU, Tsopanomihalu M, Wan Y, Chrousos GP. Protein 14\u20133-3\u03c3 interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway*. J Biol Chem. 2025;2003(278):25651\u20136. https:\/\/doi.org\/10.1074\/jbc.M302818200. Cited 2025 Oct 15.","journal-title":"J Biol Chem"},{"key":"3015_CR93","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1158\/0008-5472.CAN-15-2510","volume":"76","author":"TM Regan Anderson","year":"2016","unstructured":"Regan Anderson TM, Ma SH, Raj GV, Cidlowski JA, Helle TM, Knutson TP, et al. Breast tumor kinase (Brk\/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer. Cancer Res. 2016;76:1653\u201363. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2510.","journal-title":"Cancer Res"},{"issue":"33","key":"3015_CR94","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1128\/MCB.00150-13","volume":"2013","author":"WM Lambert","year":"2025","unstructured":"Lambert WM, Xu C-F, Neubert TA, Chao MV, Garabedian MJ, Jeanneteau FD. Brain-derived neurotrophic factor signaling rewrites the glucocorticoid transcriptome via glucocorticoid receptor phosphorylation. Mol Cell Biol Taylor & Francis. 2025;2013(33):3700\u201314. https:\/\/doi.org\/10.1128\/MCB.00150-13.","journal-title":"Mol Cell Biol Taylor & Francis"},{"issue":"2","key":"3015_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108943","volume":"27","author":"A Iyer-Bierhoff","year":"2024","unstructured":"Iyer-Bierhoff A, Wieczorek M, Peter SM, Ward D, Bens M, Vettorazzi S, et al. Acetylation-induced proteasomal degradation of the activated glucocorticoid receptor limits hormonal signaling. iScience. 2024;27(2):108943. https:\/\/doi.org\/10.1016\/j.isci.2024.108943.","journal-title":"iScience"},{"key":"3015_CR96","doi-asserted-by":"publisher","first-page":"e60452","DOI":"10.1371\/journal.pone.0060452","volume":"8","author":"A Hu","year":"2013","unstructured":"Hu A, Josephson MB, Diener BL, Nino G, Xu S, Paranjape C, et al. Pro-asthmatic cytokines regulate unliganded and ligand-dependent glucocorticoid receptor signaling in airway smooth muscle. PLoS ONE. 2013;8:e60452. https:\/\/doi.org\/10.1371\/journal.pone.0060452.","journal-title":"PLoS ONE"},{"key":"3015_CR97","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1165\/rcmb.2012-0522OC","volume":"50","author":"B Bouazza","year":"2014","unstructured":"Bouazza B, Debba-Pavard M, Amrani Y, Isaacs L, O\u2019Connell D, Ahamed S, et al. Basal p38 mitogen-activated protein kinase regulates unliganded glucocorticoid receptor function in airway smooth muscle cells. Am J Respir Cell Mol Biol. 2014;50:301\u201315. https:\/\/doi.org\/10.1165\/rcmb.2012-0522OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3015_CR98","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1210\/me.2006-0345","volume":"21","author":"T Kino","year":"2007","unstructured":"Kino T, Ichijo T, Amin ND, Kesavapany S, Wang Y, Kim N, et al. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol. 2007;21:1552\u201368. https:\/\/doi.org\/10.1210\/me.2006-0345.","journal-title":"Mol Endocrinol"},{"issue":"7","key":"3015_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022289","volume":"6","author":"L Matthews","year":"2011","unstructured":"Matthews L, Johnson J, Berry A, Trebble P, Cookson A, Spiller D, et al. Cell cycle phase regulates glucocorticoid receptor function. PLoS One. 2011;6(7):e22289. https:\/\/doi.org\/10.1371\/journal.pone.0022289.","journal-title":"PLoS One"},{"key":"3015_CR100","doi-asserted-by":"publisher","first-page":"e63587","DOI":"10.1371\/journal.pone.0063587","volume":"8","author":"SSM Ng","year":"2013","unstructured":"Ng SSM, Li A, Pavlakis GN, Ozato K, Kino T. Viral infection increases glucocorticoid-induced interleukin-10 production through ERK-mediated phosphorylation of the glucocorticoid receptor in dendritic cells: potential clinical implications. PLoS ONE. 2013;8:e63587. https:\/\/doi.org\/10.1371\/journal.pone.0063587.","journal-title":"PLoS ONE"},{"issue":"277","key":"3015_CR101","doi-asserted-by":"publisher","first-page":"26573","DOI":"10.1074\/jbc.M110530200","volume":"2002","author":"Z Wang","year":"2023","unstructured":"Wang Z, Frederick J, Garabedian MJ. Deciphering the phosphorylation \u201ccode\u201d of the glucocorticoid receptor in vivo *210. J Biol Chem. 2023;2002(277):26573\u201380. https:\/\/doi.org\/10.1074\/jbc.M110530200.","journal-title":"J Biol Chem"},{"issue":"112","key":"3015_CR102","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1073\/pnas.1411356112","volume":"2015","author":"LC Matthews","year":"2023","unstructured":"Matthews LC, Berry AA, Morgan DJ, Poolman TM, Bauer K, Kramer F, et al. Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancy. Proc Natl Acad Sci U S A. 2023;2015(112):5479\u201384. https:\/\/doi.org\/10.1073\/pnas.1411356112. Cited 2023 Oct 17.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3015_CR103","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mce.2010.06.007","volume":"327","author":"C Avenant","year":"2010","unstructured":"Avenant C, Ronacher K, Stubsrud E, Louw A, Hapgood JP. Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity. Mol Cell Endocrinol. 2010;327:72\u201388. https:\/\/doi.org\/10.1016\/j.mce.2010.06.007.","journal-title":"Mol Cell Endocrinol"},{"key":"3015_CR104","doi-asserted-by":"publisher","first-page":"110873","DOI":"10.1016\/j.mce.2020.110873","volume":"518","author":"M Patt","year":"2020","unstructured":"Patt M, Gysi J, Faresse N, Cidlowski JA, Odermatt A. Protein phosphatase 1 alpha enhances glucocorticoid receptor activity by a mechanism involving phosphorylation of serine-211. Mol Cell Endocrinol. 2020;518:110873. https:\/\/doi.org\/10.1016\/j.mce.2020.110873.","journal-title":"Mol Cell Endocrinol"},{"key":"3015_CR105","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1210\/me.2007-0219","volume":"22","author":"W Chen","year":"2008","unstructured":"Chen W, Dang T, Blind RD, Wang Z, Cavasotto CN, Hittelman AB, et al. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol. 2008;22:1754\u201366. https:\/\/doi.org\/10.1210\/me.2007-0219.","journal-title":"Mol Endocrinol"},{"key":"3015_CR106","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1210\/me.2002-0144","volume":"16","author":"M Itoh","year":"2002","unstructured":"Itoh M, Adachi M, Yasui H, Takekawa M, Tanaka H, Imai K. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol. 2002;16:2382\u201392. https:\/\/doi.org\/10.1210\/me.2002-0144.","journal-title":"Mol Endocrinol"},{"key":"3015_CR107","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00109-020-01873-3","volume":"98","author":"S Lea","year":"2020","unstructured":"Lea S, Li J, Plumb J, Gaffey K, Mason S, Gaskell R, et al. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells. J Mol Med (Berl). 2020;98:361\u201374. https:\/\/doi.org\/10.1007\/s00109-020-01873-3.","journal-title":"J Mol Med (Berl)"},{"key":"3015_CR108","doi-asserted-by":"publisher","DOI":"10.1111\/febs.70422","author":"S Srivastava","year":"2026","unstructured":"Srivastava S, Chowdhury S, Upadhyay V, Shah A, Sethi A, Mishra S, et al. Nemo-like kinase modulates glucocorticoid-induced erythroid progenitor differentiation by regulating stability of the glucocorticoid receptor. FEBS J. 2026. https:\/\/doi.org\/10.1111\/febs.70422.","journal-title":"FEBS J"},{"issue":"367","key":"3015_CR109","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1042\/BJ20021085","volume":"2002","author":"S Tian","year":"2023","unstructured":"Tian S, Poukka H, Palvimo JJ, J\u00e4nne OA. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem J. 2023;2002(367):907\u201311. https:\/\/doi.org\/10.1042\/BJ20021085. Cited 2023 Nov 7.","journal-title":"Biochem J"},{"issue":"42","key":"3015_CR110","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/nar\/gkt1033","volume":"2014","author":"V Paakinaho","year":"2024","unstructured":"Paakinaho V, Kaikkonen S, Makkonen H, Benes V, Palvimo JJ. SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor. Nucleic Acids Res. 2024;2014(42):1575\u201392. https:\/\/doi.org\/10.1093\/nar\/gkt1033. Cited 2024 Dec 11.","journal-title":"Nucleic Acids Res"},{"issue":"49","key":"3015_CR111","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/nar\/gkab032","volume":"2021","author":"V Paakinaho","year":"2023","unstructured":"Paakinaho V, Lempi\u00e4inen JK, Sigismondo G, Niskanen EA, Malinen M, J\u00e4\u00e4skel\u00e4inen T, et al. SUMOylation regulates the protein network and chromatin accessibility at glucocorticoid receptor-binding sites. Nucleic Acids Res. 2023;2021(49):1951\u201371. https:\/\/doi.org\/10.1093\/nar\/gkab032. Cited 2023 Nov 7.","journal-title":"Nucleic Acids Res"},{"key":"3015_CR112","doi-asserted-by":"publisher","first-page":"E635","DOI":"10.1073\/pnas.1522826113","volume":"113","author":"G Hua","year":"2016","unstructured":"Hua G, Ganti KP, Chambon P. Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT\/NCoR1-HDAC3 repressing complex. Proc Natl Acad Sci U S A. 2016;113:E635-643. https:\/\/doi.org\/10.1073\/pnas.1522826113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"113","key":"3015_CR113","doi-asserted-by":"publisher","first-page":"E626","DOI":"10.1073\/pnas.1522821113","volume":"2016","author":"G Hua","year":"2023","unstructured":"Hua G, Paulen L, Chambon P. GR SUMOylation and formation of an SUMO-SMRT\/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression. Proc Natl Acad Sci U S A. 2023Nov 7;2016(113):E626\u201334. https:\/\/doi.org\/10.1073\/pnas.1522821113. Cited 2023 Nov 7.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3015_CR114","doi-asserted-by":"publisher","first-page":"7309","DOI":"10.1128\/MCB.00808-08","volume":"28","author":"AJ Galliher-Beckley","year":"2008","unstructured":"Galliher-Beckley AJ, Williams JG, Collins JB, Cidlowski JA. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol Cell Biol. 2008;28:7309\u201322. https:\/\/doi.org\/10.1128\/MCB.00808-08.","journal-title":"Mol Cell Biol"},{"issue":"27","key":"3015_CR115","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/leu.2012.361","volume":"2013","author":"A Malyukova","year":"2023","unstructured":"Malyukova A, Brown S, Papa R, O\u2019Brien R, Giles J, Trahair TN, et al. FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation. Leukemia Nature Publishing Group. 2023;2013(27):1053\u201362. https:\/\/doi.org\/10.1038\/leu.2012.361. Cited 2023 Oct 19.","journal-title":"Leukemia Nature Publishing Group"},{"issue":"75","key":"3015_CR116","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.steroids.2010.06.015","volume":"2010","author":"AD Wallace","year":"2023","unstructured":"Wallace AD, Cao Y, Chandramouleeswaran S, Cidlowski JA. Lysine 419 targets human glucocorticoid receptor for proteasomal degradation. Steroids. 2023;2010(75):1016\u201323. https:\/\/doi.org\/10.1016\/j.steroids.2010.06.015.","journal-title":"Steroids"},{"key":"3015_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32440-z","volume":"8","author":"L Wilkinson","year":"2018","unstructured":"Wilkinson L, Verhoog N, Louw A. Novel role for receptor dimerization in post-translational processing and turnover of the GR\u03b1. Sci Rep. 2018;8:14266. https:\/\/doi.org\/10.1038\/s41598-018-32440-z.","journal-title":"Sci Rep"},{"issue":"294","key":"3015_CR118","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1074\/jbc.RA118.007150","volume":"2019","author":"MG Petrillo","year":"2025","unstructured":"Petrillo MG, Oakley RH, Cidlowski JA. \u03b2-Arrestin-1 inhibits glucocorticoid receptor turnover and alters glucocorticoid signaling. J Biol Chem. 2025;2019(294):11225\u201339. https:\/\/doi.org\/10.1074\/jbc.RA118.007150. Cited 2025 Oct 15.","journal-title":"J Biol Chem"},{"key":"3015_CR119","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1096\/fj.08-117697","volume":"23","author":"N Nader","year":"2009","unstructured":"Nader N, Chrousos GP, Kino T. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J. 2009;23:1572\u201383. https:\/\/doi.org\/10.1096\/fj.08-117697.","journal-title":"FASEB J"},{"key":"3015_CR120","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1084\/jem.20050466","volume":"203","author":"K Ito","year":"2006","unstructured":"Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med. 2006;203:7\u201313. https:\/\/doi.org\/10.1084\/jem.20050466.","journal-title":"J Exp Med"},{"key":"3015_CR121","doi-asserted-by":"publisher","first-page":"100551","DOI":"10.1016\/j.jbc.2021.100551","volume":"296","author":"CC Munier","year":"2021","unstructured":"Munier CC, De Maria L, Edman K, Gunnarsson A, Longo M, MacKintosh C, et al. Glucocorticoid receptor Thr524 phosphorylation by MINK1 induces interactions with 14\u20133-3 protein regulators. J Biol Chem. 2021;296:100551. https:\/\/doi.org\/10.1016\/j.jbc.2021.100551.","journal-title":"J Biol Chem"},{"issue":"33","key":"3015_CR122","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1128\/MCB.01470-12","volume":"2013","author":"J Druker","year":"2023","unstructured":"Druker J, Liberman AC, Antunica-Noguerol M, Gerez J, Paez-Pereda M, Rein T, et al. RSUME Enhances Glucocorticoid Receptor SUMOylation and Transcriptional Activity. Mol Cell Biol. 2023;2013(33):2116\u201327. https:\/\/doi.org\/10.1128\/MCB.01470-12. Cited 2023 Nov 7.","journal-title":"Mol Cell Biol"},{"key":"3015_CR123","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ymeth.2019.09.007","volume":"175","author":"C Poulard","year":"2020","unstructured":"Poulard C, Jacquemetton J, Pham TH, Le Romancer M. Using proximity ligation assay to detect protein arginine methylation. Methods. 2020;175:66\u201371. https:\/\/doi.org\/10.1016\/j.ymeth.2019.09.007.","journal-title":"Methods"},{"key":"3015_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01777-2","volume":"7","author":"M Ayrout","year":"2017","unstructured":"Ayrout M, Simon V, Bernard V, Binart N, Cohen-Tannoudji J, Lomb\u00e8s M, et al. A novel non genomic glucocorticoid signaling mediated by a membrane palmitoylated glucocorticoid receptor cross talks with GnRH in gonadotrope cells. Sci Rep. 2017;7:1537. https:\/\/doi.org\/10.1038\/s41598-017-01777-2.","journal-title":"Sci Rep"},{"key":"3015_CR125","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1016\/S0021-9258(19)83677-3","volume":"260","author":"VB Singh","year":"1985","unstructured":"Singh VB, Moudgil VK. Phosphorylation of rat liver glucocorticoid receptor. J Biol Chem. 1985;260:3684\u201390.","journal-title":"J Biol Chem"},{"key":"3015_CR126","doi-asserted-by":"publisher","first-page":"13810","DOI":"10.1016\/S0021-9258(17)38797-5","volume":"260","author":"PR Housley","year":"1985","unstructured":"Housley PR, Sanchez ER, Westphal HM, Beato M, Pratt WB. The molybdate-stabilized L-cell glucocorticoid receptor isolated by affinity chromatography or with a monoclonal antibody is associated with a 90\u201392-kDa nonsteroid-binding phosphoprotein. J Biol Chem. 1985;260:13810\u20137.","journal-title":"J Biol Chem"},{"key":"3015_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77445-9","volume":"10","author":"R Nakamura","year":"2020","unstructured":"Nakamura R, Mukudai S, Bing R, Garabedian MJ, Branski RC. Complex fibroblast response to glucocorticoids may underlie variability of clinical efficacy in the vocal folds. Sci Rep. 2020;10:20458. https:\/\/doi.org\/10.1038\/s41598-020-77445-9.","journal-title":"Sci Rep"},{"key":"3015_CR128","doi-asserted-by":"publisher","first-page":"E187","DOI":"10.1002\/lary.27570","volume":"129","author":"S Mukudai","year":"2019","unstructured":"Mukudai S, Hiwatashi N, Bing R, Garabedian M, Branski RC. Phosphorylation of the glucocorticoid receptor alters SMAD signaling in vocal fold fibroblasts. Laryngoscope. 2019;129:E187\u201393. https:\/\/doi.org\/10.1002\/lary.27570.","journal-title":"Laryngoscope"},{"key":"3015_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2008.03.036","volume":"475","author":"S Takabe","year":"2008","unstructured":"Takabe S, Mochizuki K, Goda T. De-phosphorylation of GR at Ser203 in nuclei associates with GR nuclear translocation and GLUT5 gene expression in Caco-2 cells. Arch Biochem Biophys. 2008;475:1\u20136. https:\/\/doi.org\/10.1016\/j.abb.2008.03.036.","journal-title":"Arch Biochem Biophys"},{"key":"3015_CR130","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1210\/me.2004-0528","volume":"19","author":"AL Miller","year":"2005","unstructured":"Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, et al. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol. 2005;19:1569\u201383. https:\/\/doi.org\/10.1210\/me.2004-0528.","journal-title":"Mol Endocrinol"},{"key":"3015_CR131","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1165\/rcmb.2011-0364OC","volume":"47","author":"B Bouazza","year":"2012","unstructured":"Bouazza B, Krytska K, Debba-Pavard M, Amrani Y, Honkanen RE, Tran J, et al. Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases. Am J Respir Cell Mol Biol. 2012;47:464\u201373. https:\/\/doi.org\/10.1165\/rcmb.2011-0364OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3015_CR132","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1210\/me.2010-0192","volume":"24","author":"N Nader","year":"2010","unstructured":"Nader N, Ng SSM, Lambrou GI, Pervanidou P, Wang Y, Chrousos GP, et al. AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK. Mol Endocrinol. 2010;24:1748\u201364. https:\/\/doi.org\/10.1210\/me.2010-0192. Cited 2026 May 20.","journal-title":"Mol Endocrinol"},{"key":"3015_CR133","doi-asserted-by":"publisher","first-page":"8941","DOI":"10.1038\/s41598-017-09246-6","volume":"7","author":"I Petta","year":"2017","unstructured":"Petta I, Bougarne N, Vandewalle J, Dejager L, Vandevyver S, Ballegeer M, et al. Glucocorticoid Receptor-mediated transactivation is hampered by Striatin-3, a novel interaction partner of the receptor. Sci Rep. 2017;7:8941. https:\/\/doi.org\/10.1038\/s41598-017-09246-6.","journal-title":"Sci Rep"},{"key":"3015_CR134","doi-asserted-by":"publisher","first-page":"24542","DOI":"10.1074\/jbc.M109.021469","volume":"284","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Leung DYM, Nordeen SK, Goleva E. Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation. J Biol Chem. 2009;284:24542\u201352. https:\/\/doi.org\/10.1074\/jbc.M109.021469.","journal-title":"J Biol Chem"},{"key":"3015_CR135","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jsbmb.2008.01.002","volume":"109","author":"RD Blind","year":"2008","unstructured":"Blind RD, Garabedian MJ. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J Steroid Biochem Mol Biol. 2008;109:150\u20137. https:\/\/doi.org\/10.1016\/j.jsbmb.2008.01.002.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3015_CR136","doi-asserted-by":"publisher","first-page":"8515","DOI":"10.1093\/nar\/gkt624","volume":"41","author":"TM Poolman","year":"2013","unstructured":"Poolman TM, Farrow SN, Matthews L, Loudon AS, Ray DW. Pin1 promotes GR transactivation by enhancing recruitment to target genes. Nucleic Acids Res. 2013;41:8515\u201325. https:\/\/doi.org\/10.1093\/nar\/gkt624.","journal-title":"Nucleic Acids Res"},{"key":"3015_CR137","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1128\/MCB.01121-13","volume":"34","author":"ME Peffer","year":"2014","unstructured":"Peffer ME, Chandran UR, Luthra S, Volonte D, Galbiati F, Garabedian MJ, et al. Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells. Mol Cell Biol. 2014;34:2611\u201323. https:\/\/doi.org\/10.1128\/MCB.01121-13.","journal-title":"Mol Cell Biol"},{"key":"3015_CR138","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1021\/bi901956s","volume":"49","author":"C Avenant","year":"2010","unstructured":"Avenant C, Kotitschke A, Hapgood JP. Glucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitment. Biochemistry. 2010;49:972\u201385. https:\/\/doi.org\/10.1021\/bi901956s.","journal-title":"Biochemistry"},{"key":"3015_CR139","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1210\/me.2005-0338","volume":"21","author":"Z Wang","year":"2007","unstructured":"Wang Z, Chen W, Kono E, Dang T, Garabedian MJ. Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase. Mol Endocrinol. 2007;21:625\u201334. https:\/\/doi.org\/10.1210\/me.2005-0338.","journal-title":"Mol Endocrinol"},{"key":"3015_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103577","volume":"392","author":"G Chen","year":"2025","unstructured":"Chen G, Lv S, Pascal LE, Wang Z. Regulation of glucocorticoid receptor nuclear localization in prostate cancer cells. J Pharmacol Exp Ther. 2025;392:103577. https:\/\/doi.org\/10.1016\/j.jpet.2025.103577.","journal-title":"J Pharmacol Exp Ther"},{"issue":"44","key":"3015_CR141","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41388-025-03305-3","volume":"2025","author":"E Valima","year":"2025","unstructured":"Valima E, Varis V, Bureiko K, Lempi\u00e4inen JK, Schroderus A-M, Oksa L, et al. SUMOylation inhibition potentiates the glucocorticoid receptor to program growth arrest of acute lymphoblastic leukemia cells. Oncogene Nature Publishing Group. 2025;2025(44):1259\u201371. https:\/\/doi.org\/10.1038\/s41388-025-03305-3. Cited 2025 Oct 15.","journal-title":"Oncogene Nature Publishing Group"},{"issue":"150","key":"3015_CR142","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1210\/en.2008-0587","volume":"2009","author":"AE Oakley","year":"2026","unstructured":"Oakley AE, Breen KM, Clarke IJ, Karsch FJ, Wagenmaker ER, Tilbrook AJ. Cortisol reduces gonadotropin-releasing hormone pulse frequency in follicular phase ewes: influence of ovarian steroids. Endocrinology. 2026;2009(150):341\u20139. https:\/\/doi.org\/10.1210\/en.2008-0587. Cited 2026 May 20.","journal-title":"Endocrinology"},{"issue":"287","key":"3015_CR143","doi-asserted-by":"publisher","first-page":"12904","DOI":"10.1074\/jbc.M111.303792","volume":"2012","author":"M-D Li","year":"2026","unstructured":"Li M-D, Ruan H-B, Singh JP, Zhao L, Zhao T, Azarhoush S, et al. O-GlcNAc Transferase Is Involved in Glucocorticoid Receptor-mediated Transrepression. J Biol Chem. 2026;2012(287):12904\u201312. https:\/\/doi.org\/10.1074\/jbc.M111.303792. Cited 2026 May 20.","journal-title":"J Biol Chem"},{"issue":"43","key":"3015_CR144","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1210\/endrev\/bnab014","volume":"2022","author":"L Malbeteau","year":"2025","unstructured":"Malbeteau L, Pham HT, Eve L, Stallcup MR, Poulard C, Le Romancer M. How protein methylation regulates steroid receptor function. Endocr Rev. 2025;2022(43):160\u201397. https:\/\/doi.org\/10.1210\/endrev\/bnab014.","journal-title":"Endocr Rev"},{"key":"3015_CR145","doi-asserted-by":"publisher","first-page":"111453","DOI":"10.1016\/j.mce.2021.111453.Cited2026May20","volume":"538","author":"C Thiebaut","year":"2021","unstructured":"Thiebaut C, Vlaeminck-Guillem V, Tr\u00e9dan O, Poulard C, Le Romancer M. Non-genomic signaling of steroid receptors in cancer. Mol Cell Endocrinol. 2021;538:111453. https:\/\/doi.org\/10.1016\/j.mce.2021.111453.Cited2026May20.","journal-title":"Mol Cell Endocrinol"},{"issue":"408","key":"3015_CR146","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mce.2015.01.044","volume":"2015C","author":"Q Deng","year":"2026","unstructured":"Deng Q, Waxse B, Riquelme D, Zhang J, Aguilera G. Helix 8 of the ligand binding domain of the glucocorticoid receptor (GR) is essential for ligand binding. Mol Cell Endocrinol. 2026;2015C(408):23\u201332. https:\/\/doi.org\/10.1016\/j.mce.2015.01.044. Cited 2026 May 21.","journal-title":"Mol Cell Endocrinol"},{"key":"3015_CR147","unstructured":"Nicolaides NC, Kino T, Roberts ML, Katsantoni E, Sertedaki A, Moutsatsou P, et al. The Role of S-Palmitoylation of the Human Glucocorticoid Receptor (hGR) in Mediating the Nongenomic Glucocorticoid Actions. J Mol Biochem. 2017;6:3\u201312. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5538142\/. Cited 2026 Apr 7. Accessed 7 Apr 2026"},{"key":"3015_CR148","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13058-020-01277-8","volume":"22","author":"C Perez Kerkvliet","year":"2020","unstructured":"Perez Kerkvliet C, Dwyer AR, Diep CH, Oakley RH, Liddle C, Cidlowski JA, et al. Glucocorticoid receptors are required effectors of TGF\u03b21-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer. Breast Cancer Res. 2020;22:39. https:\/\/doi.org\/10.1186\/s13058-020-01277-8.","journal-title":"Breast Cancer Res"},{"key":"3015_CR149","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqad083","volume":"164","author":"AR Dwyer","year":"2023","unstructured":"Dwyer AR, Perez Kerkvliet C, Truong TH, Hagen KM, Krutilina RI, Parke DN, et al. Glucocorticoid receptors drive breast cancer cell migration and metabolic reprogramming via PDK4. Endocrinology. 2023;164:bqad083. https:\/\/doi.org\/10.1210\/endocr\/bqad083.","journal-title":"Endocrinology"},{"issue":"16","key":"3015_CR150","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1158\/1541-7786.MCR-18-0410","volume":"2018","author":"TM Regan Anderson","year":"2025","unstructured":"Regan Anderson TM, Ma S, Perez Kerkvliet C, Peng Y, Helle TM, Krutilina RI, et al. Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR\/GR\/HIF\u2013driven Signaling Axis. Mol Cancer Res. 2025;2018(16):1761\u201372. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0410. Cited 2025 Oct 16.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"3015_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/srep37231","volume":"6","author":"M Arango-Lievano","year":"2016","unstructured":"Arango-Lievano M, Peguet C, Catteau M, Parmentier M-L, Wu S, Chao MV, et al. Deletion of neurotrophin signaling through the glucocorticoid receptor pathway causes tau neuropathology. Sci Rep. 2016;6(1):37231. https:\/\/doi.org\/10.1038\/srep37231.","journal-title":"Sci Rep"},{"issue":"1","key":"3015_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010143","volume":"16","author":"JAO Zimmerman","year":"2023","unstructured":"Zimmerman JAO, Fang M, Pufall MA. PI3K\u03b4 inhibition potentiates glucocorticoids in B-lymphoblastic leukemia by decreasing receptor phosphorylation and enhancing gene regulation. Cancers (Basel). 2023;16(1):143. https:\/\/doi.org\/10.3390\/cancers16010143.","journal-title":"Cancers (Basel)"},{"key":"3015_CR153","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/COPD.S72403","volume":"10","author":"N Khorasani","year":"2015","unstructured":"Khorasani N, Baker J, Johnson M, Chung KF, Bhavsar PK. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:283\u201391. https:\/\/doi.org\/10.2147\/COPD.S72403.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3015_CR154","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/all.13003","volume":"72","author":"L Chachi","year":"2017","unstructured":"Chachi L, Abbasian M, Gavrila A, Alzahrani A, Tliba O, Bradding P, et al. Protein phosphatase 5 mediates corticosteroid insensitivity in airway smooth muscle in patients with severe asthma. Allergy. 2017;72:126\u201336. https:\/\/doi.org\/10.1111\/all.13003.","journal-title":"Allergy"},{"issue":"33","key":"3015_CR155","doi-asserted-by":"publisher","first-page":"13998","DOI":"10.1096\/fj.201901596R","volume":"2019","author":"E Zub","year":"2025","unstructured":"Zub E, Canet G, Garbelli R, Blaqui\u00e8re M, Rossini L, Pastori C, et al. The GR-ANXA1 pathway is a pathological player and a candidate target in epilepsy. FASEB J. 2025;2019(33):13998\u20134009. https:\/\/doi.org\/10.1096\/fj.201901596R. Cited 2025 Oct 16.","journal-title":"FASEB J"},{"issue":"130","key":"3015_CR156","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1172\/JCI130363","volume":"2020","author":"H Li","year":"2024","unstructured":"Li H, Su P, Lai TKY, Jiang A, Liu J, Zhai D, et al. The glucocorticoid receptor\u2013FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder. J Clin Invest. 2024;2020(130):877\u201389. https:\/\/doi.org\/10.1172\/JCI130363. Cited 2024 Jan 11.","journal-title":"J Clin Invest"},{"key":"3015_CR157","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.psyneuen.2009.03.002","volume":"34","author":"E Bei","year":"2009","unstructured":"Bei E, Salpeas V, Pappa D, Anagnostara C, Alevizos V, Moutsatsou P. Phosphorylation status of glucocorticoid receptor, heat shock protein 70, cytochrome c and Bax in lymphocytes of euthymic, depressed and manic bipolar patients. Psychoneuroendocrinology. 2009;34:1162\u201375. https:\/\/doi.org\/10.1016\/j.psyneuen.2009.03.002.","journal-title":"Psychoneuroendocrinology"},{"key":"3015_CR158","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41375-019-0381-4","volume":"33","author":"Y Shi","year":"2019","unstructured":"Shi Y, Wang G, Muhowski EM, McCaw L, Wang C, Bjarnason G, et al. Ibrutinib reprograms the glucocorticoid receptor in chronic lymphocytic leukemia cells. Leukemia. 2019;33:1650\u201362. https:\/\/doi.org\/10.1038\/s41375-019-0381-4.","journal-title":"Leukemia"},{"key":"3015_CR159","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027627","volume":"6","author":"Y Kobayashi","year":"2011","unstructured":"Kobayashi Y, Mercado N, Barnes PJ, Ito K. Defects of Protein Phosphatase 2A Causes Corticosteroid Insensitivity in Severe Asthma. PLoS One. 2011;6:e27627. https:\/\/doi.org\/10.1371\/journal.pone.0027627.","journal-title":"PLoS One"},{"key":"3015_CR160","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.21037\/jtd-20-213","volume":"12","author":"D Wu","year":"2020","unstructured":"Wu D, Gu B, Qian Y, Sun Y, Chen Y, Mao Z-D, et al. Long non-coding RNA growth arrest specific-5: a potential biomarker for early diagnosis of severe asthma. J Thorac Dis. 2020;12:1960\u201371. https:\/\/doi.org\/10.21037\/jtd-20-213.","journal-title":"J Thorac Dis"},{"key":"3015_CR161","doi-asserted-by":"publisher","first-page":"e41582","DOI":"10.1371\/journal.pone.0041582","volume":"7","author":"N Mercado","year":"2012","unstructured":"Mercado N, Hakim A, Kobayashi Y, Meah S, Usmani OS, Chung KF, et al. Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma. PLoS ONE. 2012;7:e41582. https:\/\/doi.org\/10.1371\/journal.pone.0041582.","journal-title":"PLoS ONE"},{"issue":"109","key":"3015_CR162","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1067\/mai.2002.122465","volume":"2002","author":"E Irusen","year":"2025","unstructured":"Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM. p38 Mitogen-activated protein kinase\u2013induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol. 2025;2002(109):649\u201357. https:\/\/doi.org\/10.1067\/mai.2002.122465.","journal-title":"J Allergy Clin Immunol"},{"issue":"181","key":"3015_CR163","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1084\/jem.181.1.33","volume":"1995","author":"DY Leung","year":"2025","unstructured":"Leung DY, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, et al. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med. 2025;1995(181):33\u201340. https:\/\/doi.org\/10.1084\/jem.181.1.33. Cited 2025 Oct 16.","journal-title":"J Exp Med"},{"issue":"113","key":"3015_CR164","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jaci.2004.03.018","volume":"2004","author":"JG Matthews","year":"2025","unstructured":"Matthews JG, Ito K, Barnes PJ, Adcock IM. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol. 2025;2004(113):1100\u20138. https:\/\/doi.org\/10.1016\/j.jaci.2004.03.018. Cited 2025 Oct 16.","journal-title":"J Allergy Clin Immunol"},{"key":"3015_CR165","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pnpbp.2012.10.021","volume":"40","author":"I Simic","year":"2013","unstructured":"Simic I, Maric NP, Mitic M, Soldatovic I, Pavlovic Z, Mihaljevic M, et al. Phosphorylation of leukocyte glucocorticoid receptor in patients with current episode of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2013;40:281\u20135. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.10.021.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3015_CR166","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.molcel.2017.03.019","volume":"66","author":"F Yang","year":"2017","unstructured":"Yang F, Ma Q, Liu Z, Li W, Tan Y, Jin C, et al. Glucocorticoid receptor:megatrans switching mediates the repression of an ER\u03b1-regulated transcriptional program. Mol Cell. 2017;66:321-331.e6. https:\/\/doi.org\/10.1016\/j.molcel.2017.03.019.","journal-title":"Mol Cell"},{"key":"3015_CR167","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa041892","volume":"352","author":"K Ito","year":"2005","unstructured":"Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, et al. Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2005;352:1967\u201376. https:\/\/doi.org\/10.1056\/NEJMoa041892.","journal-title":"N Engl J Med"},{"issue":"64","key":"3015_CR168","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1021\/acs.jmedchem.0c01491","volume":"2021","author":"SP Langston","year":"2025","unstructured":"Langston SP, Grossman S, England D, Afroze R, Bence N, Bowman D, et al. Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer. J Med Chem Am Chem Soc. 2025;2021(64):2501\u201320. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01491. Cited 2025 Oct 16.","journal-title":"J Med Chem Am Chem Soc"},{"key":"3015_CR169","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1530\/ERC-20-0489","volume":"28","author":"I Mayayo-Peralta","year":"2021","unstructured":"Mayayo-Peralta I, Zwart W, Prekovic S. Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene? Endocr Relat Cancer. 2021;28:R157\u201371. https:\/\/doi.org\/10.1530\/ERC-20-0489.","journal-title":"Endocr Relat Cancer"},{"key":"3015_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094446","volume":"22","author":"LM Noureddine","year":"2021","unstructured":"Noureddine LM, Tr\u00e9dan O, Hussein N, Badran B, Le Romancer M, Poulard C. Glucocorticoid receptor: a multifaceted actor in breast cancer. Int J Mol Sci. 2021;22:4446. https:\/\/doi.org\/10.3390\/ijms22094446.","journal-title":"Int J Mol Sci"},{"key":"3015_CR171","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","volume":"567","author":"MMS Obradovi\u0107","year":"2019","unstructured":"Obradovi\u0107 MMS, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux M-M, et al. Glucocorticoids promote breast cancer metastasis. Nature. 2019;567:540\u20134. https:\/\/doi.org\/10.1038\/s41586-019-1019-4.","journal-title":"Nature"},{"issue":"1","key":"3015_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9323","volume":"6","author":"Z Chen","year":"2015","unstructured":"Chen Z, Lan X, Wu D, Sunkel B, Ye Z, Huang J, et al. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer. Nat Commun. 2015;6(1):8323. https:\/\/doi.org\/10.1038\/ncomms9323.","journal-title":"Nat Commun"},{"key":"3015_CR173","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1158\/1078-0432.CCR-12-3826","volume":"19","author":"MN Skor","year":"2013","unstructured":"Skor MN, Wonder EL, Kocherginsky M, Goyal A, Hall BA, Cai Y, et al. Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clin Cancer Res. 2013;19:6163\u201372. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3826.","journal-title":"Clin Cancer Res"},{"issue":"27","key":"3015_CR174","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ccell.2014.11.025","volume":"2015","author":"J Xu","year":"2025","unstructured":"Xu J, Acharya S, Sahin O, Zhang Q, Saito Y, Yao J, et al. 14\u20133-3\u03b6 Turns TGF-\u03b2\u2019s function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2. Cancer Cell Elsevier. 2025;2015(27):177\u201392. https:\/\/doi.org\/10.1016\/j.ccell.2014.11.025. Cited 2025 Oct 16.","journal-title":"Cancer Cell Elsevier"},{"key":"3015_CR175","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1210\/me.2015-1049","volume":"29","author":"P Ravindranathan","year":"2015","unstructured":"Ravindranathan P, Lange CA, Raj GV. Minireview: deciphering the cellular functions of PELP1. Mol Endocrinol. 2015;29:1222\u20139. https:\/\/doi.org\/10.1210\/me.2015-1049.","journal-title":"Mol Endocrinol"},{"issue":"100","key":"3015_CR176","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/cncr.11940","volume":"2004","author":"FJ Esteva","year":"2025","unstructured":"Esteva FJ, Sahin AA, Smith TL, Yang Y, Pusztai L, Nahta R, et al. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer. 2025;2004(100):499\u2013506. https:\/\/doi.org\/10.1002\/cncr.11940. Cited 2025 Oct 16.","journal-title":"Cancer"},{"key":"3015_CR177","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10549-013-2722-8","volume":"142","author":"M Vilasco","year":"2013","unstructured":"Vilasco M, Communal L, Hugon-Rodin J, Penault-Llorca F, Mourra N, Wu Z, et al. Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. Breast Cancer Res Treat. 2013;142:283\u201396. https:\/\/doi.org\/10.1007\/s10549-013-2722-8.","journal-title":"Breast Cancer Res Treat"},{"key":"3015_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2023.01.079","volume":"650","author":"S Srivastava","year":"2023","unstructured":"Srivastava S, Siddiqui S, Chowdhury S, Trivedi AK. Dexamethasone activates c-Jun NH2-terminal kinase (JNK) which interacts with GR and protects it from ubiquitin-mediated degradation in NSCLC cells. Biochem Biophys Res Commun. 2023;650:1\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.079.","journal-title":"Biochem Biophys Res Commun"},{"issue":"41","key":"3015_CR179","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10585-024-10294-2","volume":"2024","author":"P Zhai","year":"2026","unstructured":"Zhai P, Zhang H, Li Q, Hu Z, Zhang H, Yang M, et al. SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells. Clin Exp Metastasis. 2026;2024(41):747\u201364. https:\/\/doi.org\/10.1007\/s10585-024-10294-2. Cited 2026 May 20.","journal-title":"Clin Exp Metastasis"},{"key":"3015_CR180","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13213","volume":"35","author":"OC Meijer","year":"2023","unstructured":"Meijer OC, Buurstede JC, Viho EMG, Amaya JM, Koning A-S, van der Meulen M, et al. Transcriptional glucocorticoid effects in the brain: finding the relevant target genes. J Neuroendocrinol. 2023;35:e13213. https:\/\/doi.org\/10.1111\/jne.13213.","journal-title":"J Neuroendocrinol"},{"issue":"1261","key":"3015_CR181","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1749-6632.2012.06633.x","volume":"2012","author":"MN Silverman","year":"2025","unstructured":"Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its behavioral and metabolic correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci. 2025;2012(1261):55\u201363. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06633.x. Cited 2025 Oct 9.","journal-title":"Ann N Y Acad Sci"},{"issue":"70","key":"3015_CR182","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuropharm.2012.12.012","volume":"2013","author":"M Mitic","year":"2025","unstructured":"Mitic M, Simic I, Djordjevic J, Radojcic MB, Adzic M. Gender-specific effects of fluoxetine on hippocampal glucocorticoid receptor phosphorylation and behavior in chronically stressed rats. Neuropharmacology. 2025;2013(70):100\u201311. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.12.012. Cited 2025 Oct 16.","journal-title":"Neuropharmacology"},{"issue":"1","key":"3015_CR183","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40478-022-01396-7","volume":"10","author":"Y Dromard","year":"2022","unstructured":"Dromard Y, Arango-Lievano M, Borie A, Dedin M, Fontanaud P, Torrent J, et al. Loss of glucocorticoid receptor phosphorylation contributes to cognitive and neurocentric damages of the amyloid-\u03b2 pathway. Acta Neuropathol Commun. 2022;10(1):91. https:\/\/doi.org\/10.1186\/s40478-022-01396-7.","journal-title":"Acta Neuropathol Commun"},{"issue":"112","key":"3015_CR184","doi-asserted-by":"publisher","first-page":"15737","DOI":"10.1073\/pnas.1509045112","volume":"2015","author":"M Arango-Lievano","year":"2025","unstructured":"Arango-Lievano M, Lambert WM, Bath KG, Garabedian MJ, Chao MV, Jeanneteau F. Neurotrophic-priming of glucocorticoid receptor signaling is essential for neuronal plasticity to stress and antidepressant treatment. Proc Natl Acad Sci U S A. 2025;2015(112):15737\u201342. https:\/\/doi.org\/10.1073\/pnas.1509045112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"335","key":"3015_CR185","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/0140-6736(90)91445-G","volume":"1990","author":"NJ Goulding","year":"2025","unstructured":"Goulding NJ, Godolphin JL, Sharland PR, Maddison PJ, Sampson M, Peers SH, et al. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet. 2025;1990(335):1416\u20138. https:\/\/doi.org\/10.1016\/0140-6736(90)91445-G. Cited 2025 Oct 16.","journal-title":"Lancet"},{"key":"3015_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2020.104800","volume":"120","author":"H-Y Lin","year":"2020","unstructured":"Lin H-Y, Liu Y-S, Huang C-Y, Cathomas F, Liu K, Wang J, et al. SUMO E3 ligase PIAS1 is a potential biomarker indicating stress susceptibility. Psychoneuroendocrinology. 2020;120:104800. https:\/\/doi.org\/10.1016\/j.psyneuen.2020.104800.","journal-title":"Psychoneuroendocrinology"},{"issue":"120","key":"3015_CR187","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jsbmb.2010.03.058","volume":"2010","author":"U Baschant","year":"2026","unstructured":"Baschant U, Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol. 2026;2010(120):69\u201375. https:\/\/doi.org\/10.1016\/j.jsbmb.2010.03.058. Cited 2026 May 20.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"3015_CR188","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","volume":"2011","author":"M Zen","year":"2026","unstructured":"Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, et al. The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev. 2026;2011(10):305\u201310. https:\/\/doi.org\/10.1016\/j.autrev.2010.11.009. Cited 2026 May 20.","journal-title":"Autoimmun Rev"},{"key":"3015_CR189","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1183\/09031936.00036707","volume":"31","author":"T Renda","year":"2008","unstructured":"Renda T, Baraldo S, Pelaia G, Bazzan E, Turato G, Papi A, et al. Increased activation of p38 MAPK in COPD. Eur Respir J. 2008;31:62\u20139. https:\/\/doi.org\/10.1183\/09031936.00036707.","journal-title":"Eur Respir J"},{"issue":"338","key":"3015_CR190","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1124\/jpet.111.180737","volume":"2011","author":"J Armstrong","year":"2025","unstructured":"Armstrong J, Harbron C, Lea S, Booth G, Cadden P, Wreggett KA, et al. Synergistic Effects of p38 Mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease. J Pharmacol Exp Therapeut. 2025;2011(338):732\u201340. https:\/\/doi.org\/10.1124\/jpet.111.180737. Cited 2025 Oct 16.","journal-title":"J Pharmacol Exp Therapeut"},{"key":"3015_CR191","doi-asserted-by":"publisher","DOI":"10.3390\/biology12081104","volume":"12","author":"S Bhaumik","year":"2023","unstructured":"Bhaumik S, Lockett J, Cuffe J, Clifton VL. Glucocorticoids and Their Receptor Isoforms: Roles in Female Reproduction, Pregnancy, and Foetal Development. Biology (Basel). 2023;12:1104. https:\/\/doi.org\/10.3390\/biology12081104.","journal-title":"Biology (Basel)"},{"issue":"157","key":"3015_CR192","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1210\/en.2015-1711","volume":"2016","author":"E Luo","year":"2025","unstructured":"Luo E, Stephens SBZ, Chaing S, Munaganuru N, Kauffman AS, Breen KM. Corticosterone blocks ovarian cyclicity and the LH surge via decreased kisspeptin neuron activation in female mice. Endocrinology. 2025;2016(157):1187\u201399. https:\/\/doi.org\/10.1210\/en.2015-1711. Cited 2025 Oct 14.","journal-title":"Endocrinology"},{"key":"3015_CR193","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1210\/endo-59-2-165","volume":"59","author":"AT Bever","year":"1956","unstructured":"Bever AT, Hisaw FL, Velardo JT. Inhibitory action of desoxycorticosterone acetate, cortisone acetate, and testosterone on uterine growth induced by estradiol-17beta. Endocrinology. 1956;59:165\u20139. https:\/\/doi.org\/10.1210\/endo-59-2-165.","journal-title":"Endocrinology"},{"key":"3015_CR194","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1210\/endo-80-3-423","volume":"80","author":"J Bitman","year":"1967","unstructured":"Bitman J, Cecil HC. Differential inhibition by cortisol of estrogen-stimulated uterine responses. Endocrinology. 1967;80:423\u20139. https:\/\/doi.org\/10.1210\/endo-80-3-423.","journal-title":"Endocrinology"},{"issue":"3","key":"3015_CR195","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12672-012-0103-0","volume":"2012","author":"S Whirledge","year":"2025","unstructured":"Whirledge S, Dixon D, Cidlowski JA. Glucocorticoids regulate gene expression and repress cellular proliferation in human uterine leiomyoma cells. Horm Cancer. 2025;2012(3):79\u201392. https:\/\/doi.org\/10.1007\/s12672-012-0103-0.","journal-title":"Horm Cancer"},{"key":"3015_CR196","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1210\/en.2016-1464","volume":"157","author":"W Wang","year":"2016","unstructured":"Wang W, Liu C, Sun K. Induction of amnion epithelial apoptosis by cortisol via tPA\/Plasmin system. Endocrinology. 2016;157:4487\u201398. https:\/\/doi.org\/10.1210\/en.2016-1464.","journal-title":"Endocrinology"},{"key":"3015_CR197","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1210\/me.2004-0068","volume":"19","author":"TM Wintermantel","year":"2005","unstructured":"Wintermantel TM, Bock D, Fleig V, Greiner EF, Sch\u00fctz G. The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production. Mol Endocrinol. 2005;19:340\u20139. https:\/\/doi.org\/10.1210\/me.2004-0068.","journal-title":"Mol Endocrinol"},{"key":"3015_CR198","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/eje.0.1450519","volume":"145","author":"HM Reichardt","year":"2001","unstructured":"Reichardt HM, Horsch K, Gr\u00f6ne HJ, Kolbus A, Beug H, Hynes N, et al. Mammary gland development and lactation are controlled by different glucocorticoid receptor activities. Eur J Endocrinol. 2001;145:519\u201327. https:\/\/doi.org\/10.1530\/eje.0.1450519.","journal-title":"Eur J Endocrinol"},{"key":"3015_CR199","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1210\/endo.143.1.8584","volume":"143","author":"MN Berg","year":"2002","unstructured":"Berg MN, Dharmarajan AM, Waddell BJ. Glucocorticoids and progesterone prevent apoptosis in the lactating rat mammary gland. Endocrinology. 2002;143:222\u20137. https:\/\/doi.org\/10.1210\/endo.143.1.8584.","journal-title":"Endocrinology"},{"issue":"149","key":"3015_CR200","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1210\/en.2007-0773","volume":"2008","author":"KM Breen","year":"2026","unstructured":"Breen KM, Davis TL, Doro LC, Nett TM, Oakley AE, Padmanabhan V, et al. Insight into the Neuroendocrine Site and Cellular Mechanism by which Cortisol Suppresses Pituitary Responsiveness to Gonadotropin-Releasing hormone. Endocrinology. 2026;2008(149):767\u201373. https:\/\/doi.org\/10.1210\/en.2007-0773. Cited 2026 May 20.","journal-title":"Endocrinology"},{"issue":"872","key":"3015_CR201","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-2895-8_5","volume":"2015","author":"T Kuo","year":"2025","unstructured":"Kuo T, McQueen A, Chen T-C, Wang J-C. Regulation of glucose homeostasis by glucocorticoids. Adv Exp Med Biol. 2025;2015(872):99\u2013126. https:\/\/doi.org\/10.1007\/978-1-4939-2895-8_5.","journal-title":"Adv Exp Med Biol"},{"key":"3015_CR202","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jsbmb.2010.02.010","volume":"122","author":"AJ Rose","year":"2010","unstructured":"Rose AJ, Vegiopoulos A, Herzig S. Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations. J Steroid Biochem Mol Biol. 2010;122:10\u201320. https:\/\/doi.org\/10.1016\/j.jsbmb.2010.02.010.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"3015_CR203","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9010022","volume":"9","author":"SJ Burke","year":"2020","unstructured":"Burke SJ, Taylor JL, Batdorf HM, Noland RC, Burk DH, Yu Y, et al. The Ubiquitin Ligase SIAH2 Negatively Regulates Glucocorticoid Receptor Activity and Abundance. Biomedicines. 2020;9(1):22. https:\/\/doi.org\/10.3390\/biomedicines9010022.","journal-title":"Biomedicines"},{"key":"3015_CR204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41375-023-02082-w","volume":"38","author":"Y Liu","year":"2026","unstructured":"Liu Y, Karlsson S. Perspectives of current understanding and therapeutics of Diamond-Blackfan anemia. Leukemia. 2026;38:1\u20139. https:\/\/doi.org\/10.1038\/s41375-023-02082-w.","journal-title":"Leukemia"},{"key":"3015_CR205","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17100-z","volume":"11","author":"MC Wilkes","year":"2020","unstructured":"Wilkes MC, Siva K, Chen J, Varetti G, Youn MY, Chae H, et al. Diamond Blackfan anemia is mediated by hyperactive Nemo-like kinase. Nat Commun. 2020;11:3344. https:\/\/doi.org\/10.1038\/s41467-020-17100-z.","journal-title":"Nat Commun"},{"key":"3015_CR206","doi-asserted-by":"publisher","DOI":"10.3390\/biom9030095","volume":"9","author":"R Kumar","year":"2019","unstructured":"Kumar R, Thompson EB. Role of Phosphorylation in the Modulation of the Glucocorticoid Receptor\u2019s Intrinsically Disordered Domain. Biomolecules. 2019;9:95. https:\/\/doi.org\/10.3390\/biom9030095.","journal-title":"Biomolecules"},{"key":"3015_CR207","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tem.2008.10.001","volume":"20","author":"SJ Han","year":"2026","unstructured":"Han SJ, Lonard DM, O\u2019Malley BW. Multi-modulation of nuclear receptor coactivators through posttranslational modifications. Trends Endocrinol Metab. 2026;20:8\u201315. https:\/\/doi.org\/10.1016\/j.tem.2008.10.001.","journal-title":"Trends Endocrinol Metab"},{"key":"3015_CR208","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1073\/pnas.1816254116","volume":"116","author":"C Poulard","year":"2019","unstructured":"Poulard C, Kim HN, Fang M, Kruth K, Gagnieux C, Gerke DS, et al. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2019;116:3052\u201361. https:\/\/doi.org\/10.1073\/pnas.1816254116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3015_CR209","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38584-5","volume":"14","author":"RA Lee","year":"2023","unstructured":"Lee RA, Chang M, Yiv N, Tsay A, Tian S, Li D, et al. Transcriptional coactivation by EHMT2 restricts glucocorticoid-induced insulin resistance in a study with male mice. Nat Commun. 2023;14(1):3143. https:\/\/doi.org\/10.1038\/s41467-023-38584-5.","journal-title":"Nat Commun"},{"key":"3015_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101227","volume":"8","author":"B Liu","year":"2019","unstructured":"Liu B, Zhang T-N, Knight JK, Goodwin JE. The glucocorticoid receptor in cardiovascular health and disease. Cells. 2019;8:1227. https:\/\/doi.org\/10.3390\/cells8101227.","journal-title":"Cells"},{"key":"3015_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01666-8","volume":"7","author":"M Pantaleon","year":"2017","unstructured":"Pantaleon M, Steane SE, McMahon K, Cuffe JSM, Moritz KM. Placental O-GlcNAc-transferase expression and interactions with the glucocorticoid receptor are sex specific and regulated by maternal corticosterone exposure in mice. Sci Rep. 2017;7:2017. https:\/\/doi.org\/10.1038\/s41598-017-01666-8.","journal-title":"Sci Rep"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03015-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03015-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03015-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:37:45Z","timestamp":1789601865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-03015-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":211,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3015"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03015-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.T. received honoraria and grants from: Roche, Pfizer, Novartis, Lilly, MSD, Astra-Zeneca, Seagen, Daiichi-Sankyo, Gilead, BMS, Sandoz, Viatris, Menarini-Stemline, Veracyte, Exact Sciences.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"494"}}